Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study
Titel:
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study
Auteur:
Aravantinos, G. Fountzilas, G. Kosmidis, P. Dimopoulos, M.A. Stathopoulos, G.P. Pavlidis, N. Bafaloukos, D. Papadimitriou, C. Karpathios, S. Georgoulias, V. Papakostas, P. Kalofonos, H.P. Grimani, E. Skarlos, D.V.